Drug Shortage Report for GLUCOPHAGE
Report ID | 199227 |
Drug Identification Number | 02099233 |
Brand name | GLUCOPHAGE |
Common or Proper name | GLUCOPHAGE |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | METFORMIN HYDROCHLORIDE |
Strength(s) | 500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 500 |
ATC code | A10BA |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2023-07-17 |
Estimated end date | 2023-08-31 |
Actual end date | 2023-08-31 |
Shortage status | Resolved |
Updated date | 2023-09-01 |
Company comments | Manufacturing delay. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2023-09-01 | English | Compare |
v4 | 2023-08-31 | French | Compare |
v3 | 2023-08-31 | English | Compare |
v2 | 2023-07-19 | French | Compare |
v1 | 2023-07-19 | English | Compare |
Showing 1 to 5 of 5